Langenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to personalized dendritic cell therapy for glioblastoma in Germany. The findings, based on a documented Canadian patient case and supporting clinical research, highlight how cross-border treatment pathways may provide patients with aggressive brain tumors access to individualized immunotherapy options that are not widely available within all healthcare systems.
Two-week anniversary promotion gives Canadian families $100 off campground delivery, helping them stay closer to the lake, the water park, or the family reunion.OTTAWA,...
Centennial exhibition exploring Marilyn Monroe's intellect, discipline and self-authorshipRare archival personal items, audio and imagery, plus programming and culinary experiences across Genesis HouseNEW YORK,...
GLASGOW, Scotland, Aug. 13, 2025 (GLOBE NEWSWIRE) -- In a move set to redefine the delivery of world-class sporting events, Glasgow 2026 Commonwealth Games has appointed Trivandi, a global leader in the planning, design and operational delivery of major events as Official Event Delivery Partner.
GUANGZHOU, China, Aug. 11, 2025 /PRNewswire/ -- GAC is forging world-class chassis technology by synergizing top-tier international engineering expertise with China's signature innovation speed,...
STAFFORD, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today provided the following update on CEO interviews and corporate events.
28-Year-Old From Samaná, Colombia Claims Podium Spot in Fourth Stop of SLS World TourCLEVELAND, Aug. 10, 2025 /PRNewswire/ -- Rising to the podium! Monster...
GLP-1 Plus by Advanced BioNutritionals enters the spotlight with a patented dihydroberberine (DHB) formula in 2025, reflecting rising interest in GLP-1 alternatives and non-injection hunger support solutions.
GLP-1 Plus by Advanced BioNutritionals enters the spotlight with a patented dihydroberberine (DHB) formula in 2025, reflecting rising interest in GLP-1 alternatives and non-injection hunger support solutions.